CHAMPIONS ONCOLOGY, INC. Revenues
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Revenues of $2.90 million for the 12-month period ending 2019-04-30, per its 10-K filed 2020-07-28.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2020-07-28
- CHAMPIONS ONCOLOGY, INC. revenues for the quarter ending 2018-07-31 was $6.22M, a 23.68% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. revenues for the quarter ending 2017-07-31 was $5.03M.
- CHAMPIONS ONCOLOGY, INC. revenues for fiscal 2019 was $2.90M.
| Period end | Revenues 3 month | Revenues 12 month |
|---|---|---|
| 2019-04-30 | $2.90M 10-K · filed 2020-07-28 | |
| 2018-07-31 | $6.22M 10-Q · filed 2018-09-14 | |
| 2017-07-31 | $5.03M 10-Q · filed 2018-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |